Kursprognose für Apimeds Pharmaceuticals US Inc (APUS)

$2.685

-0.044 (-1.65%)Zum Schluss

Kursprognosen

1-Day Price Prediction

+1.09%

1-Week Prediction

+1.57%

1-Month Prediction

—

2026 Prediction

—

2030 Prediction

—

In der App öffnen, um Prognosen mit längerem Horizont freizuschalten.

Loading chart…

APUS-Prognose durch Analyse ähnlicher Charts

Alphio's APUS stock price prediction model matches the current Apimeds Pharmaceuticals US Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $2.71 (+1.09%). The 1-week path is $2.73 (+1.57%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Soll ich Apimeds Pharmaceuticals US Inc-Aktien kaufen?

Apimeds Pharmaceuticals US Inc is not a good buy right now due to its significant financial losses and poor technical indicators. The current price is $2.68, and the company has reported a staggering net income loss of $35,059,852 in Q1 2026. Additionally, the RSI is at 26.149, indicating that the stock is oversold, but this does not suggest a buying opportunity given the ongoing financial instability.

APUS schloss am Friday bei $2.68, nachdem der Kurs -1.65% fallen

Apimeds Pharmaceuticals US Inc (APUS) last closed at $2.6849999, losing -1.65%. These facts feed the 1-day and 1-week APUS price prediction above.

Prognose-Treiber

Die Prognose-Treiber von Apimeds Pharmaceuticals US Inc (APUS) kombinieren ähnliche Chartmuster, Saisonalität und gleitende Durchschnitte.

Similar patterns

Negative

Bearish

Seasonality

Positive

Bullish

SMA 20

Negative

Bearish

SMA 200

Negative

Bearish

Saisonalitätsanalyse für APUS

Historically the probability of a positive November return for APUS is 66.67%. April offers the highest probability of a positive month at 100.00%, while June is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.

Loading chart…